Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 61 AL 75

Targeting the gut-brain axis with Bifidobacterium breve in neurodegeneration: A comprehensive narrative review of current evidence in Alzheimer's disease and cognitive aging

Hamzeh O, Halaji M, Rostami A, Md Ashraf G.

J Alzheimers Dis. 2026 Oct 22:13872877261496277. doi: 10.1177/13872877261496277. Online ahead of print.

Pathogenesis and therapeutic targets of neuroinflammation in Alzheimer's disease mediated by microglia lysosomal dysfunction

Zi M, Ye Q, Yao M, Feng J, Meng S, Wu X, Jiang H, Yang F, Huang Y, Hu X, Ma C, Zheng J, Zeng S, Li H.

J Alzheimers Dis. 2026 Oct 22:13872877261500025. doi: 10.1177/13872877261500025. Online ahead of print.

Spatial Signatures of Retinal Neurodegeneration in Glaucoma, Alzheimer's Disease, and Carotid Stenosis

Qiu S, Cao L, Zhang J, Zhao N, Hu X, Wu B, Lu Q.

Transl Vis Sci Technol. 2026 Oct 5;15(10):38. doi: 10.1167/tvst.15.10.38.

Carbonic anhydrase inhibition rescues heart function in the Tg2576 Alzheimer's mouse model by ameliorating cardiac amyloid-β pathology and neurotrophic-signaling impairment

Elia A, Vazquez-Torres R, Carey A, Wolf M, Gade VR, Alves M, Fossati S.

bioRxiv [Preprint]. 2026 Oct 9:2026.10.08.757731. doi: 10.64898/2026.10.08.757731.

Deubiquitinating Enzymes in Alzheimer's Disease: From Protein Homeostasis to Diverse Pathological Processes

Shi X, Chen G, Wang X, Ma R, Li G.

Biomolecules. 2026 Oct 14;16(10):1494. doi: 10.3390/biom16101494.

EP2 and EP4 in Alzheimer's Disease: Cell-Dependent Signalling and Implications for Selective Targeting

Zhao X, Zeng Y, Song Z, He J, He Q, Lin H, Liu L, Yu W, Cheng S.

Int J Mol Sci. 2026 Oct 16;27(20):9190. doi: 10.3390/ijms27209190.

Natural Compounds and Their Microbiota-Derived Metabolites as Modulators of the Microbiota-Gut-Brain Axis in Alzheimer Disease: Biochemical Mechanisms and Drug Discovery Insights-A Narrative Review

Cavalluzzi MM, Terlizzi F, Catalano A, Pannunzio A, Rotondo NP, Habtemariam S, Lentini G.

Molecules. 2026 Oct 17;31(20):3728. doi: 10.3390/molecules31203728.

Prevalence and clinical implications of Rapid eye movement sleep behavior disorder in Alzheimer's disease and Lewy body dementia

Yang J, Xue W, Zhang H, Tang C.

Geroscience. 2026 Oct;48(5):6757-6774. doi: 10.1007/s11357-025-01973-3. Epub 2025 Dec 2.

Hospital-treated infection associated with Alzheimer's disease pathology: underlying mechanisms

Barichello T, Scaini G, Tayyab M, Dal-Pizzol HR, Petronilho F, Dal-Pizzol F.

Mol Psychiatry. 2026 Oct;31(10):6020-6033. doi: 10.1038/s41380-026-03690-5. Epub 2026 Jun 15.

The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective

Catakli D, Ozen-Basoglu O, Tuncgovde EB, Ozsarlak-Sozer G.

Basic Clin Pharmacol Toxicol. 2026 Oct;139(4):e70294. doi: 10.1111/bcpt.70294.

Prevalence of metabolic syndrome among patients with Alzheimer disease: A systematic review and meta-analysis

Amouzad-Lichahi M, Petkov I, Smerat A, Alsarhan HW, Letafatkar N, Abbasnejad-Ardehroudkenari M, Mohammadi S, Jafari M, Ghodous S, Amini-Salehi E.

Medicine (Baltimore). 2026 Oct 2;105(40):e50670. doi: 10.1097/MD.0000000000050670.

Tobacco-attributable burden of alzheimer's disease and other dementias in China and ASEAN: Temporal trends and projections - an observational study based on GBD 2021

Wen P, Liu W, Li Y, Liao M, Qin H, Ye J, Deng Z, Cui S, Zhao Y, Wang X, Huang Y, Tang H, Qin H, Wang K, Qin Q.

Medicine (Baltimore). 2026 Oct 9;105(41):e50974. doi: 10.1097/MD.0000000000050974.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias